Thomas E. Cummin

Portsmouth, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Journal: Leukemia

Published: November 06, 2025

Management of secondary central nervous system lymphoma.

Management of secondary central nervous system lymphoma.

Journal: British journal of haematology

Published: August 13, 2022

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.

Journal: Blood advances

Published: March 18, 2022

Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit.

Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit.

Journal: Leukemia

Published: May 01, 2019

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 08, 2018

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.

Journal: The Lancet. Oncology

Published: September 11, 2018

Genetics of Diffuse Large B-Cell Lymphoma.

Genetics of Diffuse Large B-Cell Lymphoma.

Journal: The New England journal of medicine

Published: August 03, 2018

Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality.

Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: February 07, 2018

Lymphoma: turning biology into cures.

Lymphoma: turning biology into cures.

Journal: Clinical medicine (London, England)

Published: December 14, 2016

Showing 1-9 of 9

Last Updated: 09/26/2026